News Briefs Archive

Free COPE Dry Eye Webinar: “New Therapeutic Approaches and Challenges for the Treatment of Dry Eyes”

July 9, 2020

As part of Dry Eye Awareness month,the Intrepid Eye Society has partnered with the Tear Film & Ocular Surface Society to present “New Therapeutic Approaches and Challenges for the Treatment of Dry Eyes,” 1 hour COPE Pending, taught by David A. Sullivan, MS, PhD, FARVO.

The webinar will take place July 16, 2020, 8:30 p.m. Eastern Time.

Dry eye disease (DED) afflicts hundreds of millions of people throughout the world and is one of the most frequent causes of patient visits to eyecare practitioners, Dr. Sullivan writes in his course description: “DED is a symptomatic disease, characterized by a vicious cycle of hyperosmolarity and tear film instability, which leads to increased ocular surface inflammation, damage and neurosensory abnormalities. Moderate to severe DED is often associated with significant pain, limitations in performing daily activities, reduced vitality, poor general health, and depression.

Register Now

Click HERE to register for “New Therapeutic Approaches and Challenges for the Treatment of Dry Eyes”

There is no safe and effective global treatment for DED, and its therapy remains a profound unmet need. A virtual kaleidoscope of new therapeutic approaches has been proposed to treat aqueous- deficient and/or evaporative DED.”

Dr. Sullivan’s presentation will highlight these approaches, and also address the significant clinical endpoint challenges that serve as barriers to the successful development of potential treatments for DED.

Dr. Sullivan is a Ph.D. graduate of Dartmouth Medical School (Hanover, NH), an Associate Professor in the Department of Ophthalmology at Harvard Medical School and a Senior Scientist at the Schepens Eye Research Institute (SERI; Boston, MA). During the past 37 years, his research has focused on the interrelationships between sex, sex steroids and dry eye disease, as well as on the role of lubricin on the ocular surface.

>>Click HERE to register for “New Therapeutic Approaches and Challenges for the Treatment of Dry Eyes”>>

To Top
  
Subscribe Today Free...
And join more than 25,000 optometric colleagues who have made Review of Optometric Business their daily business advisor.
YOUR EMAIL
FIRST NAME
LAST NAME
  
Subscribe Today Free...
And join more than 25,000 optometric colleagues who have made Review of Optometric Business their daily business advisor.
YOUR EMAIL
FIRST NAME
LAST NAME
Subscribe Today for Free...
And join more than 35,000 optometric colleagues who have made Review of Optometric Business their daily business advisor.
Subscribe Today for Free...
And join more than 35,000 optometric colleagues who have made Review of Optometric Business their daily business advisor.